• PAD4-IN-2 TFA: Precision Tumor Targeting and Immune Modulati

  2026-05-29

  PAD4-IN-2 TFA (Compound 5i TFA) uniquely enables tumor-selective inhibition of PAD4, providing robust suppression of histone H3 citrullination and NET formation without direct cytotoxicity. Its PBA modification empowers researchers to dissect and modulate the tumor immune microenvironment with high precision and minimal toxicity.

• CBD Attenuates Orofacial Inflammatory Pain via Endocannabino

  2026-05-29

  This study demonstrates that cannabidiol (CBD) robustly reduces both sensory and affective components of orofacial inflammatory pain in mice, elucidating a multi-level mechanism involving FAAH downregulation and endocannabinoid signaling modulation. These findings highlight the translational potential of targeting the endocannabinoid system for effective management of pain and emotional comorbidities.

• Finger Citron Mechanisms Against NAFLD: Network and qPCR Ins

  2026-05-28

  This study integrates network pharmacology, molecular docking, and in vitro validation to elucidate how finger citron and its constituent TMC counteract non-alcoholic fatty liver disease (NAFLD). The findings clarify multi-target molecular mechanisms and highlight advanced qPCR strategies for gene expression analysis.

• Oseltamivir acid (A3689): Reliable Neuraminidase Inhibitor S

  2026-05-28

  This article addresses real-world challenges in influenza antiviral and oncology research, highlighting how Oseltamivir acid (SKU A3689) delivers reproducible, data-driven results for cell viability and cytotoxicity assays. Informed by literature and practical workflow considerations, it guides biomedical researchers toward robust experimental outcomes using Oseltamivir acid.

• Immune Cell Rejuvenation Mitigates Alzheimer’s Pathology in

  2026-05-27

  This research demonstrates that transplanting young bone marrow into aged Alzheimer’s model mice rejuvenates peripheral immune cells, leading to reduced amyloid pathology and cognitive deficits. The findings highlight immune system rejuvenation as a promising therapeutic strategy for neurodegenerative disease.

• Medroxyprogesterone Acetate: Expanding Horizons in Hormone S

  2026-05-27

  Explore how Medroxyprogesterone acetate (MPA) enables breakthrough insights into hormone signaling, renal physiology, and neurobiology. This article reveals unique mechanistic perspectives and advanced research protocols that set MPA apart in experimental design.

• Defining Skeletal Myogenic Lineage in Human PSC-Derived Tera

  2026-05-26

  Pappas et al. (2022) provide a comprehensive single-cell transcriptomic analysis of skeletal myogenic lineage emergence within human pluripotent stem cell-derived teratomas. Their work identifies distinct developmental subpopulations and new surface markers, offering a scalable model for isolating functional skeletal muscle progenitors for regenerative medicine.

• Praeruptorin A Suppresses HCC Metastasis via ERK/MMP1 Pathwa

  2026-05-26

  This study demonstrates that praeruptorin A inhibits migration and invasion of human hepatocellular carcinoma (HCC) cells by modulating the ERK/MMP1 signaling axis. The findings offer mechanistic insight into antimetastatic phytochemical actions and highlight avenues for targeted HCC therapy development.

• High-Throughput In Vitro BBB Model for CNS Drug Screening

  2026-05-25

  Hu et al. present an advanced surrogate blood-brain barrier model that integrates LLC-PK1-MOCK/MDR1 cells with lysosomal trapping correction, enabling high-throughput prediction of CNS drug permeability. This platform demonstrates strong in vitro–in vivo correlation, addressing major challenges in early-stage neurological drug discovery and streamlining candidate prioritization.

• EdU Flow Cytometry Assay Kits (Cy5): S-Phase DNA Synthesis A

  2026-05-25

  EdU Flow Cytometry Assay Kits (Cy5) offer researchers a reproducible, no-denaturation approach for quantifying S-phase DNA synthesis in proliferating cells. This kit is best suited for detailed cell cycle studies, cancer research, and genotoxicity workflows requiring high sensitivity and compatibility with multiplexed detection. It is not intended for use outside flow cytometry or in non-proliferation-related assays.

• CBD Modulates FAAH and Endocannabinoid Pathways in Orofacial

  2026-05-24

  This study demonstrates that cannabidiol (CBD) mitigates both sensory and affective components of orofacial inflammatory pain by downregulating FAAH and modulating endocannabinoid signaling through CB1 and CB2 receptors. The multi-dimensional findings underscore CBD’s translational potential for comprehensive pain management and highlight mechanistic avenues for future research.

• RG7388 MDM2 Antagonist: Optimizing p53 Pathway in Oncology

  2026-05-23

  RG7388, a next-generation MDM2 antagonist, enables robust p53 pathway activation for precise cancer cell apoptosis and tumor inhibition, especially in wild-type p53 models. This guide delivers protocol-driven workflows, troubleshooting strategies, and actionable insights for integrating RG7388 into advanced oncology research.

• AZD2461: Novel PARP Inhibitor Transforming DNA Repair Resear

  2026-05-22

  AZD2461 stands out as a novel PARP inhibitor for interrogating DNA repair, overcoming Pgp-mediated drug resistance, and modeling therapeutic responses in BRCA1-mutated tumor systems. This guide bridges robust assay workflows, troubleshooting, and actionable parameters to accelerate breast cancer research with APExBIO’s next-generation compound.

• Transmission Dynamics of Carbapenemase Genes in CREC in Guan

  2026-05-22

  This study systematically characterizes carbapenemase-encoding genes (CEGs) in carbapenem-resistant Enterobacter cloacae from eight teaching hospitals in Guangdong, China, during the COVID-19 pandemic. Its findings reveal high rates of multidrug resistance, detailed gene transfer mechanisms, and epidemiological patterns that inform future strategies for combating carbapenem-resistant infections.

• Genotyping Kit for Target Alleles: Rapid DNA Prep for PCR

  2026-05-21

  The Genotyping Kit for target alleles of insects, tissues, fishes and cells offers single-tube, phenol-free genomic DNA preparation, drastically reducing hands-on time for PCR-based genotyping. The kit supports diverse sample types and eliminates the need for hazardous reagents, improving workflow efficiency and minimizing cross-contamination risks. This dossier details the kit's biological rationale, mechanism, and validated use-cases.

16292 records 1/1087 page Next 12345 下5页 Last page